Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors.

Front Cardiovasc Med · 2022 · PMC9372296 · PMID 35966512

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Of note, the reduction in overall all-cause mortality but also cardiovascular mortality remained highly significant after propensity score weighting of groups ( Table 3 ; Figure 7 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.